BayMark Health Services announced the acquisition of Counseling Solutions, a medication-assisted treatment provider with locations in Chatsworth, GA and Brasstown, NC. Since 2016, Counseling Solutions has built a strong reputation for providing high quality, patient-focused medication-assisted treatment services. BayMark’s plan is to continue to build upon that same high level of patient care under its MedMark Treatment Centers brand, while further improving access to needed treatment.

“As the Federal Program Sponsor and co-owner of both Counseling Solutions locations, as well as a passionate patient advocate, I wanted to be sure we worked with an organization who had a similar philosophy to us regarding patient care,” said Zac Talbott, Treatment Center Director in Chatsworth. “Our shared commitment to the overall well-being of our patients assures me that a high level of care will be maintained throughout this transition and carried into the future. I’m excited to stay onboard in my role as Director in Chatsworth and join the BayMark Health Services team.”

MedMark Treatment Centers provides outpatient medication-assisted treatment (MAT) for opiate addiction and dependency. Medication-assisted treatment is the use of medications, such as methadone and buprenorphine, in combination with addiction counseling and behavioral therapies, to provide an evidence-based, comprehensive approach to recovery.

David K. White, Ph.D., Chief Executive Officer of BayMark Health Services, remarked, “BayMark’s mission is to provide comprehensive medication-assisted treatment for opioid use disorder and improve the lives of the patients we serve. The need for proven treatment for opioid addiction has never been greater. BayMark will build on the foundation of excellence established by Counseling Solutions and continue that mission as a part of the MedMark and BayMark family. We are very excited that Zac Talbott will provide continuity of care for our patients and a strong focus on quality going forward.”

This article originally appeared in an article on PRWeb.